TOVA DIAMOND: Open Payments
NPI 1790113660 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$353 in 19 payments from 10 companies in 2025. Trend: 2023 $1,147 · 2024 $508 · 2025 $353
Food & beverage: $353
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Janssen Biotech, Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| QOL Medical, LLC | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $17 |
| GE HEALTHCARE | 1 | $17 |
Products named: CREON, ENTYVIO, XIFAXAN, LINZESS, RINVOQ, TREMFYA, DUPIXENT, IBSRELA.
Industry payments across NJ — which companies pay providers there.
